Department Of Medicine And Therapeutics 1
1. 30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve: The Hydra CE Study
2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
3. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
4. Global Hospitalization Trends for Crohns Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
5. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
6. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
7. Global evolution of inflammatory bowel disease across epidemiologic stages
8. Global evolution of inflammatory bowel disease across epidemiologic stages
9. Advancing the global public health agenda for NAFLD: a consensus statement
10. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
11. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
12. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
13. The case for simplifying and using absolute targets for viral hepatitis elimination goals
14. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
15. Global burden of metabolic diseases, 1990–2021
16. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
17. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
18. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
1